Cost-Utility Analysis of Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip and Total Knee Replacement Surgeries in the English National Health Service

Cost-Utility Analysis of Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip and Total Knee Replacement Surgeries in the English National Health Service

Background: Major orthopedic surgery, such as elective total hip replacement (eTHR) and elective total knee replacement (eTKR), are associated with a higher risk of venous thromboembolism (VTE) than other surgical procedures. Little is known, however, about the cost-effectiveness of VTE prophylaxis...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Dalia M. Dawoud, David Wonderling, Jessica Glen, Sedina Lewis, Xavier L. Griffin, Beverley J. Hunt, Gerard Stansby, Michael Reed, Nigel Rossiter, Jagjot Kaur Chahal, Carlos Sharpin, Peter Barry
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Frontiers Media S.A. 2018-11-01
Saila:Frontiers in Pharmacology
Gaiak:
venous thromboembolism (VTE) prophylaxis
pharmacoeconomics
cost utility analysis (CUA)
total knee replacement (TKR)
total hip replacement (THR)
direct-acting oral anticoagulants
Sarrera elektronikoa:https://www.frontiersin.org/article/10.3389/fphar.2018.01370/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2018.01370/full

Antzeko izenburuak